1 |
梁计陵, 谢金凤, 王岑依, 等. microRNA在衰老性肌萎缩和运动干预中的调节作用[J]. 生理学报, 2020, 72(5): 667-676.
|
2 |
HOFFMANN C, WEIGERT C. Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations[J]. Cold Spring Harb., 2017, 7(11): 1-22.
|
3 |
VAN H G. Cytokines: muscle protein and amino acid metabolism[J]. Curr. Opin. Clin. Nutr. Metab. Care., 2012, 15(1): 85-91.
|
4 |
COHEN S, NATHAN J A, GOLDBERG A L. Muscle wasting in disease: molecular mechanisms and promising therapies[J]. Nat. Rev. Drug Discov., 2015, 14(1): 58-74.
|
5 |
WANG Y, LIU Q, QUAN H, et al.. Nutraceuticals in the prevention and treatment of the muscle atrophy[J]. Nutrients, 2021, 13(6): 1-36.
|
6 |
YIN L, LI N, JIA W, et al.. Skeletal muscle atrophy: from mechanisms to treatments[J/OL]. Pharmacol. Res., 2021, 172: 105807[2022-05-18]. .
|
7 |
KUNZ H E, DORSCHNER J M, BERENT T E, et al.. Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting[J]. J. Biol. Chem., 2020, 295(51): 17441-17459.
|
8 |
MALISZEWSKA K, ADAMSKA-PATRUNO E, KRĘTOWSKI A. The interplay between muscle mass decline, obesity, and type 2 diabetes[J]. Pol. Arch. Intern. Med., 2019, 129(11): 809-816.
|
9 |
LI Q, WU J, HUANG J, et al.. Paeoniflorin ameliorates skeletal muscle atrophy in chronic kidney disease via AMPK/SIRT1/PGC-1α-mediated oxidative stress and mitochondrial dysfunction[J/OL]. Front. Pharmacol., 2022, 13: 859723[2022-05-18]. .
|
10 |
ROY B, CURTIS M E, FEARS L S, et al.. Molecular mechanisms of obesity-induced osteoporosis and muscle atrophy[J/OL]. Front. Physiol., 2016, 7: 439[2022-05-18]. .
|
11 |
TAKEMOTO Y, FUKADA S I. Molecular mechanism maintaining muscle satellite cells and the roles in sarcopenia[J]. Clinical. Calcium, 2017, 27(3): 339-344.
|
12 |
BRAY G A. Obesity is a chronic, relapsing neurochemical disease[J]. Int. J. Obes. (Lond), 2004, 28(1): 34-38.
|
13 |
ZHANG L, WANG Z, WANG X, et al.. Prevalence of overweight and obesity in China: results from a cross-sectional study of 441 thousand adults, 2012-2015[J]. Obes. Res. Clin. Pract., 2020, 14(2): 119-126.
|
14 |
国家卫生健康委疾病预防控制局.中国居民营养与慢性病状况报告[M]. 北京:人民卫生出版社, 2021年.
|
15 |
LIPINA C, HUNDAL H S. Lipid modulation of skeletal muscle mass and function[J]. J. Cachexia Sarcopenia Muscle, 2017, 8(2): 190-201.
|
16 |
JUNG H W, KANG A N, KANG S Y, et al.. The root extract of Pueraria lobata and its main compound, puerarin, prevent obesity by increasing the energy metabolism in skeletal muscle[J]. Nutrients, 2017, 9(1): 1-13.
|
17 |
CHOI W H, SON H J, JANG Y J, et al.. Apigenin ameliorates the obesity-induced skeletal muscle atrophy by attenuating mitochondrial dysfunction in the muscle of obese mice[J/OL]. Mol. Nutr. Food Res., 2017, 61:1700218[2022-05-18]. .
|
18 |
KHALIL R. Ubiquitin-proteasome pathway and muscle atrophy[J]. Adv. Exp. Med. Biol., 2018, 1088: 235-248.
|
19 |
XU G, JAFFREY S R. Proteomic identification of protein ubiquitination events[J]. Biotechnol Genet. Eng. Rev., 2013, 29(1): 73-109.
|
20 |
ABRIGO J, RIVERA J C, ARAVENA J, et al.. High fat diet-induced skeletal muscle wasting is decreased by mesenchymal stem cells administration: implications on oxidative stress, ubiquitin proteasome pathway activation, and myonuclear apoptosis[J/OL]. Oxid. Med. Cell Longev., 2016, 2016: 9047821[2022-05-18]. .
|
21 |
BOLLINGER L M, POWELL J J, HOUMARD J A, et al.. Skeletal muscle myotubes in severe obesity exhibit altered ubiquitin-proteasome and autophagic/lysosomal proteolytic flux[J]. Obesity, 2015, 23(6): 1185-1193.
|
22 |
MASIERO E, SANDRI M. Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles[J]. Autophagy, 2010, 6(2): 307-309.
|
23 |
MIZUSHIMA N, KUMA A. Autophagosomes in GFP-LC3 transgenic mice[J]. Methods Mol. Biol., 2008, 445: 119-124.
|
24 |
JOKL E J, BLANCO G. Disrupted autophagy undermines skeletal muscle adaptation and integrity[J]. Mamm. Genome., 2016, 27(11-12): 525-537.
|
25 |
HAN S, CUI C, ZHAO X, et al.. Filamin C regulates skeletal muscle atrophy by stabilizing dishevelled-2 to inhibit autophagy and mitophagy[J]. Mol. Ther. Nucl. Acids, 2022, 27: 147-164.
|
26 |
MASIERO E, AGATEA L, MAMMUCARI C, et al.. Autophagy is required to maintain muscle mass[J]. Cell Metab., 2009, 10(6): 507-515.
|
27 |
FAN Z, XIAO Q. Impaired autophagic flux contributes to muscle atrophy in obesity by affecting muscle degradation and regeneration[J]. Biochemistry, 2020, 525(2): 462-468.
|
28 |
CHO D K, CHOI D H, CHO J Y. Effect of treadmill exercise on skeletal muscle autophagy in rats with obesity induced by a high-fat diet[J]. J. Nutr. Biochem., 2017, 21(3): 26-34.
|
29 |
CAMPBELL T L, MITCHELL A S, MCMILLAN E M, et al.. High-fat feeding does not induce an autophagic or apoptotic phenotype in female rat skeletal muscle[J]. Exp. Biol. Med., 2015, 240(5): 657-668.
|
30 |
HERRENBRUCK A R, BOLLINGER L M. Role of skeletal muscle autophagy in high-fat-diet-induced obesity and exercise[J]. Nutr. Rev., 2020, 78(1): 56-64.
|
31 |
ZHOU J C, WANG J L, REN H Z, et al.. Autophagy plays a double-edged sword role in liver diseases[J]. J. Physiol. Biochem., 2022, 78(1): 9-17.
|
32 |
LAPLANTE M, SABATINI D M. mTOR signaling in growth control and disease[J]. Cell, 2012, 149(2): 274-293.
|
33 |
HAY N, SONENBERG N. Upstream and downstream of mTOR[J]. Genes. Dev., 2004, 18(16): 1926-1945.
|
34 |
YOON M S. mTOR as a key regulator in maintaining skeletal muscle mass[J/OL]. Front. Physiol., 2017, 8: 788[2022-05-18]. .
|
35 |
KUBICA N, BOLSTER D R, FARRELL P A, et al.. Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bϵ mRNA in a mammalian target of rapamycin-dependent manner[J]. J. Biol. Chem., 2005, 280(9): 7570-7580.
|
36 |
SUN Y N, HUANG J Q, CHEN Z Z, et al.. Amyotrophy induced by a high-fat diet is closely related to inflammation and protein degradation determined by quantitative phosphoproteomic analysis in skeletal muscle of C57BL/6 J mice[J]. J. Nutr., 2020, 150(2): 294-302.
|
37 |
LEE S, KIM M B, KIM C, et al.. Whole grain cereal attenuates obesity-induced muscle atrophy by activating the PI3K/Akt pathway in obese C57BL/6N mice[J]. Food Sci. Biotechnol., 2018, 27(1): 159-168.
|
38 |
BURNETT P E, BARROW R K, COHEN N A, et al.. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1[J]. Proc. Natl. Acad. Sci. USA, 1998, 95(4): 1432-1437.
|
39 |
FANG Y, VILELLA-BACH M, BACHMANN R, et al.. Phosphatidic acid-mediated mitogenic activation of mTOR signaling[J]. Science, 2001, 294(5548): 1942-1945.
|
40 |
MCKINNELL I W, RUDNICKI M A. Molecular mechanisms of muscle atrophy[J]. Cell, 2004, 119(7): 907-910.
|
41 |
CHENG T L, LIN Z Y, LIAO K Y, et al.. Magnesium lithospermate B attenuates high-fat diet-induced muscle atrophy in C57BL/6J mice[J/OL]. Nutrients, 2021, 14(1):104[2022-05-18] .
|
42 |
BEHARRY A W, SANDESARA P B, ROBERTS B M, et al.. HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy[J]. J. Cell Sci., 2014, 127(Pt7): 1441-1453.
|
43 |
RODRIGUEZ J, VERNUS B, CHELH I, et al.. Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways[J]. Cell. Mol. Life Sci., 2014, 71(22): 4361-4371.
|
44 |
REBBAPRAGADA A, BENCHABANE H, WRANA J L, et al.. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis[J]. Mol. Cell Biol., 2003, 23(20): 7230-7242.
|
45 |
张凤奇, 庄朋伟, 林映雪, 等. 骨骼肌萎缩信号通路的研究进展[J]. 现代药物与临床, 2013, 28(4): 624-627.
|
46 |
KUMAGAI H, COELHO A R, WAN J, et al.. MOTS-c reduces myostatin and muscle atrophy signaling[J/OL]. Am. J. Physiol. Endocrinol., 2021, 320(4): E680-E690[2022-05-18]. .
|
47 |
DONG J, DONG Y, DONG Y, et al.. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues[J]. Int. J. Obes., 2016, 40(3): 434-442.
|
48 |
AMOR M, ITARIU B K, MORENO-VIEDMA V, et al.. Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans[J]. Exp. Clin. Endocrinol. Diabetes, 2019, 127(8): 550-556.
|
49 |
TANAKA M, MASUDA S, YAMAKAGE H, et al.. Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients[J]. Diabetes Res. Clin. Pract., 2018, 142: 195-202.
|
50 |
GOODMAN M N. Interleukin-6 induces skeletal muscle protein breakdown in rats[J]. Proc. Soc. Exp. Biol. Med., 1994, 205(2): 182-185.
|
51 |
DE BENEDETTI F, ALONZI T, MORETTA A, et al.. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation[J]. J. Clin. Invest., 1997, 99(4): 643-650.
|
52 |
RUI L, YUAN M, FRANTZ D, et al.. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2[J]. J. Biol. Chem., 2002, 277(44): 42394-42398.
|
53 |
JOHNSON D E, O'KEEFE R A, GRANDIS J R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer[J]. Nat. Rev. Clin. Oncol., 2018, 15(4): 234-248.
|
54 |
PELLEGRINELLI V, ROUAULT C, RODRIGUEZ-CUENCA S, et al.. Human adipocytes induce inflammation and atrophy in muscle cells during obesity[J]. Diabetes, 2015, 64(9): 3121-3134.
|
55 |
ANDRICH D E, OU Y, MELBOUCI L, et al.. Altered lipid metabolism impairs skeletal muscle force in young rats submitted to a short-term high-fat diet[J/OL]. Front. Physiol., 2018, 9: 1327[2022-07-04]. .
|
56 |
ANDRICH D E, MELBOUCI L, OU Y, et al.. A short-term high-fat diet alters glutathione levels and IL-6 gene expression in oxidative skeletal muscles of young rats[J/OL]. Front. Physiol., 2019, 10: 372[2022-07-04]. .
|
57 |
COLLINS R A, GROUNDS M D. The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha(-/-) and TNF-alpha(-/-)/LT-alpha(-/-) mice[J]. J. Histochem. Cytochem., 2001, 49(8): 989-1001.
|
58 |
HOU L, JIANG F, HUANG B, et al.. Dihydromyricetin resists inflammation-induced muscle atrophy via ryanodine receptor-CaMKK-AMPK signal pathway[J]. J. Cell Mol. Med., 2021, 25(21): 9953-9971.
|
59 |
CHEN Y, QIAN Q, YU J. Carbenoxolone ameliorates insulin sensitivity in obese mice induced by high fat diet via regulating the IκB-α/NF-κB pathway and NLRP3 inflammasome[J/OL]. Biomed., 2019, 115: 108868[2022-05-18]. .
|
60 |
KIM K H, JEONG Y T, OH H, et al.. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine[J]. Nat. Med., 2013, 19(1): 83-92.
|
61 |
MORALES-SCHOLZ M G, SWINTON C, MURPHY R M, et al.. Autophagy is not involved in lipid accumulation and the development of insulin resistance in skeletal muscle[J]. Biochemistry, 2021, 534: 533-539.
|
62 |
郑莉芳, 陈佩杰, 周永战, 等. 骨骼肌中脂肪沉积及其调节机制[J]. 生理学报, 2017, 69(3): 344-350.
|
63 |
RUAN J, ZHANG Y, YUAN J, et al.. A long-term high-fat, high-sucrose diet in Bama minipigs promotes lipid deposition and amyotrophy by up-regulating the myostatin pathway[J]. Mol. Cell Endocrinol., 2016, 425: 123-132.
|
64 |
VERPOORTEN S, SFYRI P, SCULLY D, et al.. Loss of CD36 protects against diet-induced obesity but results in impaired muscle stem cell function, delayed muscle regeneration and hepatic steatosis[J/OL]. Acta Physiol. (Oxford, England), 2020, 228(3): e13395[2022-05-18]. .
|
65 |
POWERS S K, WIGGS M P, DUARTE J A, et al.. Mitochondrial signaling contributes to disuse muscle atrophy[J]. Am. J. Physiol. Endocrinol. Metab., 2012, 303(1): 31-39.
|
66 |
ROMANELLO V, GUADAGNIN E, GOMES L, et al.. Mitochondrial fission and remodelling contributes to muscle atrophy[J]. Embo. J., 2010, 29(10): 1774-1785.
|
67 |
TEZZE C, ROMANELLO V, DESBATS M A, et al.. Age-associated loss of OPA1 in muscle impacts muscle mass, metabolic homeostasis, systemic inflammation, and epithelial senescence[J]. Cell Metab., 2017, 25(6): 1374-1389.
|